As of June 2022 FibroGen has a market cap of $1.08 Billion. This makes FibroGen the world's 4244th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.08 B | -17.07% |
2021 | $1.30 B | -61.27% |
2020 | $3.37 B | -10.21% |
2019 | $3.75 B | -4.91% |
2018 | $3.95 B | 1.48% |
2017 | $3.89 B | 188.26% |
2016 | $1.35 B | -28.44% |
2015 | $1.88 B | 17% |
2014 | $1.61 B |
On Jun 24th, 2022 the market cap of FibroGen was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Illumina ILMN | $30.46 B | 2,710.25% | ๐บ๐ธ USA |
![]() Acceleron Pharma XLRN | $10.93 B | 908.34% | ๐บ๐ธ USA |
![]() Accelerate Diagnostics AXDX | $0.10 B | -90.03% | ๐บ๐ธ USA |